|
MCART2 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.560800E-03 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.716700E-03 |
| Normal-vs-Stage2 |
5.634300E-02 |
| Normal-vs-Stage3 |
4.016400E-02 |
| Normal-vs-Stage4 |
3.668300E-02 |
| Stage1-vs-Stage2 |
8.453800E-01 |
| Stage1-vs-Stage3 |
9.755400E-01 |
| Stage1-vs-Stage4 |
7.659400E-01 |
| Stage2-vs-Stage3 |
8.921200E-01 |
| Stage2-vs-Stage4 |
6.959400E-01 |
| Stage3-vs-Stage4 |
7.919400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.223400E-03 |
| Normal-vs-AfricanAmerican |
3.803600E-01 |
| Normal-vs-Asian |
5.220600E-03 |
| Caucasian-vs-AfricanAmerican |
3.565400E-01 |
| Caucasian-vs-Asian |
2.270800E-01 |
| AfricanAmerican-vs-Asian |
1.141960E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.939800E-02 |
| Normal-vs-Female |
6.544900E-03 |
| Male-vs-Female |
8.030200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.929600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.683600E-03 |
| Normal-vs-Age(61-80Yrs) |
5.942100E-02 |
| Normal-vs-Age(81-100Yrs) |
6.060800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.808400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.720800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.119200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.739200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.679800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.058600E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.481200E-01 |
| Classical-VS-Follicular |
6.161400E-01 |
| Classical-VS-Other |
4.152000E-02 |
| Classical-VS-Normal |
2.896400E-02 |
| Tall-VS-Follicular |
5.884800E-01 |
| Tall-VS-Other |
1.051960E-01 |
| Tall-VS-Normal |
3.701900E-02 |
| Follicular-VS-Other |
7.825700E-02 |
| Follicular-VS-Normal |
3.798300E-02 |
| Other-VS-Normal |
6.608100E-04 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.155100E-03 |
| Normal-vs-N1 |
2.369700E-02 |
| N0-vs-N1 |
6.825000E-01 |
|
|
